Mr. Sanner is an attorney who practices intellectual property law with a focus on the life sciences. Mr. Sanner has experience with patent prosecution, litigation matters, patent post-grant proceedings, and legal opinions in the biotechnology and pharmaceutical areas. Prior to beginning his career as an attorney, Mr. Sanner gathered over five years of experience in both academic and industry laboratories, with technologies ranging from analytical chemistry to research on neuronal trafficking mechanisms.
Experience
- Utility patent prosecution at all stages, for technologies including antibodies, small molecule drugs, cell cultures, treatment methods, battery components, recombinant microorganisms, and many others.
- Patent Office post-grant proceedings, including inter partes review
- Litigation practice including discovery, motion practice, briefing, and more.
- Legal opinions including invalidity, non-infringement, and other due diligence review.
Articles, Publications & Lectures
- James Sanner, The Struggle For CRISPR: A Billion Dollar Question in Intellectual Property, 2 U. ILL. J. L. TECH. & POL’Y 431 (2016).
Practices
Technologies
Insights
- Steve Sklar and James Sanner Present IPO Webinar “The Future of Pharma Patents: Recent Trends and Challenges”
February 21, 2024 - Leydig Hosts University of Illinois College of Law IP Legal Society
January 11, 2023 - ‘Secret’ Sales Treated the Same Under the AIA’s ‘On-Sale Bar,’ Supreme Court Says
April 24, 2019